Ziccum () | Spotlight

Please note that April 30 is a half trading day on the Swedish stock exchange and the market will close at 13:00. Friday, May 1 is a public holiday in Sweden, and the Swedish market will therefore be closed. For more information, please see Spotlight’s opening hours on the website.

Ziccum is a Swedish pharmaceutical company that develops new preparations of biological drugs. With their patented technology, LaminarPace, the company develops dry preparations of products currently only available in liquid form. The company is based in Lund.

Quotes for Ziccum AB

+/-
%




()

Board

CEO

Göran Conradsson

Chairperson of the Board

Fredrik Sjövall

Board

Kristian Kierkegaard
Mattias Münnich
Mikaela Bruhammar
Ola Camber

Articles of association

News

2020-11-16 12:32:50 Spotlight: Market Notice 280/20 – Ziccum AB will be delisted after close of the market on November 30, 2020
2020-11-11 12:52:49 Ziccum AB genomför listbyte till Nasdaq First North Growth Market och offentliggör bolagsbeskrivning
2020-11-11 12:52:49 Ziccum AB carries out list change to Nasdaq First North Growth Market and releases company description
2020-11-06 08:00:00 ZICCUM AB Delårsrapport 1 januari-30 september 2020
2020-11-06 08:00:00 ZICCUM AB interim report January 1-September 30, 2020

Analysis

2020-08-21 Penser Research: Ziccum: En teknologi på en marknad med hela världens fokus - Penser
2020-04-20 Penser Research: Ziccum: Stort steg framåt med nytt samarbete - Penser
2020-02-14 Penser Research: Ziccum: Nyheter kring samarbeten att vänta 2020 - Penser
2019-11-12 Penser Research: Ziccum: Eliminera kylkedjan för vaccin - Penser
2018-09-28 SvD Börsplus: Riskabel resa från vått till torrt

Ziccum AB

Quotes for Ziccum AB

Board

News

Analysis

Videos

Ziccum har fått ett större intresse globalt med anledning av pandemin

Ziccum ska effektivisera hanteringen av vaccin globalt

Ziccum om patentansökan kring Adenovirus

Ziccums Noteringsceremoni

Annual reports, prospectus etc.